Yuze Wu
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 6
-
- Optical Network Technologies 5
- Semiconductor Lasers and Optical Devices 3
- Advanced Photonic Communication Systems 3
- Photonic and Optical Devices 3
- Co-authors
- Kongming Wu (14 shared papers)Ming Yi (13 shared papers)Mengke Niu (11 shared papers)Qi Mei (3 shared papers)Shuangli Zhu (5 shared papers)Tianye Li (4 shared papers)Ming Yi (1 shared paper)Haoxiang Zhang (1 shared paper)
In The Last Decade
Yuze Wu
30 papers receiving 1.4k citations
Yuze Wu's Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology 562
- Oncology 528
- Cancer Research 148
- Biotechnology 51
- Molecular Biology 362
Countries citing papers authored by Yuze Wu
This map shows the geographic impact of Yuze Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuze Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuze Wu more than expected).
Fields of papers citing papers by Yuze Wu
This network shows the impact of papers produced by Yuze Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuze Wu. The network helps show where Yuze Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuze Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy Hit paper breakdown → | 2022 | 304 |
| 2 | Targeting cytokine and chemokine signaling pathways for cancer therapy Hit paper breakdown → | 2024 | 223 |
| 3 | Recent advances in targeted strategies for triple-negative breast cancer Hit paper breakdown → | 2023 | 188 |
| 4 | 2022 | 126 | |
| 5 | Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer Hit paper breakdown → | 2022 | 122 |
| 6 | 2021 | 113 | |
| 7 | 2023 | 68 | |
| 8 | 2021 | 63 | |
| 9 | 2022 | 60 | |
| 10 | 2019 | 29 | |
| 11 | 2025 | 19 | |
| 12 | 2024 | 17 | |
| 13 | 2024 | 17 | |
| 14 | 2021 | 16 | |
| 15 | 2022 | 14 | |
| 16 | 2023 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2022 | 8 | |
| 19 | 2023 | 6 | |
| 20 | 2004 | 6 |
About Yuze Wu
Yuze Wu is a scholar working on Oncology, Electrical and Electronic Engineering, Immunology, Control and Systems Engineering and Molecular Biology, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Optical Network Technologies (5 papers), Semiconductor Lasers and Optical Devices (3 papers), Immunotherapy and Immune Responses (3 papers), Advanced Photonic Communication Systems (3 papers), Photonic and Optical Devices (3 papers), Flood Risk Assessment and Management (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Immunology (562 citations), Oncology (528 citations), Cancer Research (148 citations), Biotechnology (51 citations) and Molecular Biology (362 citations). Yuze Wu has collaborated with scholars based in China, Ireland and Japan. Frequent co-authors include Kongming Wu, Ming Yi, Mengke Niu, Qi Mei, Shuangli Zhu, Tianye Li, Ming Yi, Haoxiang Zhang, Pengfei Zhou and Yuheng Yan. Their work appears in journals such as Journal of Hematology & Oncology, Experimental Hematology and Oncology, Water, Advanced Science and Biomarker Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.